Search clinical trials for: Severe hospitalized influenza

Total 12917 results

Association Clinique Thérapeutique Infantile du...
Centre National de Référence des staphylocoques; GFRUP (Groupe Francophone... and other collaborators

Recruiting

CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit (CAPRICE)

Severe Infection | Hospitalized Children | Invasive Bacterial Infection

France
Institut National de la Santé Et de la Recherche...

Completed

Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults (FLUVAC EV-03)

Severe Acute Respiratory Infection

France
Hoffmann-La Roche

Completed

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

Influenza

Spain, United States, Korea, Republic of, Belgium, Germany, Hong Kong, Serbia, China, Israel, Turkey, Estonia, Singapore, France, Netherlands, Finland, Canada, Sweden, Japan, Brazil, Mexico, Ukraine, Bulgaria, Czechia, Australia, New Zealand and more
Ansun Biopharma, Inc.

Unknown

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19) (STOP-Flu)

Influenza Infection | SAD-RV Infection and COVID-19

China
Chinese University of Hong Kong
Hoffmann-La Roche

Completed

A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza

Respiratory Tract Infections | Influenza

Hong Kong
Sheba Medical Center

Recruiting

Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient

Personality Disorders | Depressive Disorder | Mood Disorders | Schizophrenia | Schizoaffective Disorder | Anxiety Disorders | Bipolar Disorder | Severe Mental Disorder | Psychotic Episode

Israel
University Hospital, Strasbourg, France

Recruiting

Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD (Head-Trauma)

Head Trauma

France
Children's Hospital of Philadelphia
Genentech, Inc.

Recruiting

Xofluza-Wearables Feasibility-Study

Infections | Influenza | Transplant | Infection Viral | Infection, Coronavirus

United States
Peking University People's Hospital

Recruiting

The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

Severe Aplastic Anemia

China
AusDiagnostics Pty Ltd.

Not yet recruiting

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Respiratory Viral Infection
Assistance Publique - Hôpitaux de Paris

Recruiting

Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia (CAT-CAP)

Community-Acquired Pneumonia

France
University of Nebraska

Recruiting

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Respiratory Tract Infections

United States
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
Columbia University
National Institute on Drug Abuse (NIDA); University of Miami; Emory University; The Emmes Company, LLC

Recruiting

Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients (CTN0121)

Substance Use Disorders | Injection Site Infection

United States
Bluejay Diagnostics, Inc.

Recruiting

Symphony IL-6 Study in Patients at Risk of Severe Sepsis

Severe Sepsis

United States
Indiana University

Recruiting

Intervention to Change Affect Recognition and Empathy (ICARE)

Traumatic Brain Injury | Concussion, Severe | Concussion, Intermediate | Concussion With Brief Loss of Consciousness | Traumatic Brain Injury With Brief Loss of Consciousness | Traumatic Brain Injury With No Loss of Consciousness | Concussion With LOC 31 to 59 Minutes | Traumatic Brain Injury With... and other conditions

United States
Indiana University
Congressionally Directed Medical Research Programs; National Intrepid Center...

Recruiting

Building Emotional Self-Awareness Teletherapy (BEST) (BEST)

Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, Intermediate | Concussion; Syndrome | Concussion Injury of Cerebrum | Concussion With Brief Loss of Consciousness | Alexithymia

United States
ANRS, Emerging Infectious Diseases
P95; I-REIVAC; EPICONCEPT; Institut de Recherche en Santé Publique, France

Recruiting

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults (RESPIVAC)

COVID-19 | Influenza | Severe Acute Respiratory Infection (SARI)

France
Frontier Biotechnologies Inc.

Recruiting

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

COVID-19

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Early Oseltamivir Carboxylate Low Plasma Concentration in Patients Admitted to Intensive Care for Severe Influenza (OPTIFLU)

Severe Influenza

France
Fab'entech

Recruiting

Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome

COVID-19

Greece
Pfizer

Recruiting

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

COVID-19

United States, United Kingdom, Mexico, South Africa, Japan, Bulgaria, Hungary, Puerto Rico
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease (SEVARVIR)

SARS-CoV2 Infection | Mutation | COVID-19 Acute Respiratory Distress Syndrome

France
International Vaccine Institute

Not yet recruiting

Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. (ECOVA-01)

COVID-19 Disease
University of Washington
Centers for Disease Control and Prevention

Recruiting

Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza) (SARI-PREP)

Pneumonia, Viral

United States
ANRS, Emerging Infectious Diseases
European and Developing Countries Clinical Trials Partnership (EDCTP); European...

Recruiting

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (DATURA)

Tuberculosis | HIV-1-infection | Immuno-Deficiency

Uganda, Cambodia, Cameroon, Guinea, Vietnam, Zambia
M.D. Anderson Cancer Center

Recruiting

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

Hematopoietic and Lymphoid Cell Neoplasm | Influenza

United States
Corat Therapeutics Gmbh

Recruiting

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Covid19

Germany
Patricia Schlagenhauf
University Hospital, Geneva; Swiss Tropical & Public Health Institute; ETH Zurich and other collaborators

Not yet recruiting

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (ITIT)

Diarrhea | Malaria | Influenza | SARS-CoV Infection | Dengue | Chikungunya | Zika | Travel-Related Illness | MERS

Switzerland
Genova Inc.

Recruiting

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 (NOVATION-1)

Covid19

Turkey, Malaysia, Brazil, Argentina, Canada, Chile, Colombia, Indonesia, Kenya, Peru, South Africa, Ukraine
Sinocelltech Ltd.

Recruiting

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Covid19

United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru
AB Science

Recruiting

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

COVID-19 | SARS-CoV 2 | Coronavirus Disease 2019

France
GlaxoSmithKline

Recruiting

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

Arthralgia | Influenza, Human

Spain, United Kingdom, Poland, Netherlands
University of Oxford
Bill and Melinda Gates Foundation; Department for International Development... and other collaborators

Recruiting

Randomised Evaluation of COVID-19 Therapy (RECOVERY)

Severe Acute Respiratory Syndrome

Ghana, Indonesia, Nepal, South Africa, United Kingdom, Vietnam, India
University Hospital, Montpellier

Recruiting

Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care. (DIPREA)

Primary Immunodeficiency

France
Bassett Healthcare
Genentech, Inc.; Viroclinics Biosciences B.V.

Recruiting

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) (COMBO 1)

Influenza

United States
Chinese University of Hong Kong

Recruiting

Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia

Influenza

Hong Kong
Masonic Cancer Center, University of Minnesota

Recruiting

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Myelodysplastic Syndromes | Fanconi Anemia | Dyskeratosis Congenita | Severe Aplastic Anemia | Bone Marrow Failure | T Cell Receptor Alpha/Beta Depletion | Telomere Biology Disorder

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Influenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
Dompé Farmaceutici S.p.A

Completed

Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.

Pneumonia, Viral

United States, Italy
CTI BioPharma

Terminated

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

COVID-19 | COVID | COVID19

United States
Imperial College London

Terminated

Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (PREDICT-ILI)

RNA Virus Infections | Respiratory Tract Infections | Covid19 | Influenza | Infection, Bacterial | SARS (Severe Acute Respiratory Syndrome) | Respiratory Viral Infection | Infection Viral

United Kingdom
Regeneron Pharmaceuticals

Terminated

COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease

SARS-CoV-2

United States
MiNK Therapeutics

Completed

Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2

Respiratory Distress Syndrome, Adult

United States
Emergent BioSolutions

Completed

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Influenza A H3N2 | Influenza A H1N1

United States, Spain, Canada, Puerto Rico
ModernaTX, Inc.

Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Influenza | SARS-CoV-2 | RSV

United Kingdom, Australia, United States
Pfizer

Withdrawn

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.

COVID-19 | Influenza | Coronavirus Disease 2019
Medical University of Warsaw

Active, not recruiting

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Obesity | Vaccine Adverse Reaction | Vaccine Reaction | Influenza | Tolerance | Pregnancy; Infection | Elderly Infection

Poland
Assistance Publique - Hôpitaux de Paris
Hospices Civils de Lyon; Sanofi Pasteur, a Sanofi Company

Completed

Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients (FLUO)

Morbid Obesity | Severe Obesity

France
Pharming Technologies B.V.

Completed

Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Confirmed Coronavirus Disease

United States

Search clinical trials for: Severe hospitalized influenza

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations